Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) of the Salivary Gland Is Associated with Improved Prognosis When Arising in a Background of Sjögren’s Disease and May Not Benefit from Local Therapy

Amie E Jackson, MD, Michael Mian, Christina H. Kalpadakis, MD, Gerassimos A Pangalis, MD, Anastasios Stathis, MD, Elena Porro, MSc, Ellen D McPhail, MD, Thomas M Habermann, MD, Kay M. Ristow, Franco Cavalli, MD, Grzegorz S. Nowakowski, MD, Emanuele Zucca, MD

Blood (2014) 124 (21): 1637.

https://doi.org/10.1182/blood.V124.21.1637.1637

Published: 2014

Journal Articles

The Addition of sFLCR Improves ISS Prognostication in Multiple Myeloma (MM).

Blood (2007) 110 (11): 1490.

https://doi.org/10.1182/blood.V110.11.1490.1490

Published: 2007

Journal Articles

Serum Free Light Chain Ratio (FLCR) at Diagnosis Constitute a Powerful Prognostic Factor of Survival in Multiple Myeloma (MM).

Marie-Christine Kyrtsonis, MD, Theodoros P. Vassilakopoulos, MD, Nicoletta Kafasi, MD, Sotirios Sachanas, MD, Tatiana Tzenou, MD, Argiroula Papadogiannis, MD, Zacharoula Galanis, MD, Christina Kalpadakis, MD, Maria Dimou, MD, Elias Kyriakou, MD, Maria K. Angelopoulou, MD, Maria N. Dimopoulou, MD, Marina P. Siakantaris, MD, Styliani I. Kokoris, MD, Evangelia M. Dimitriadou, MD, Panayiotis Panayiotidis, MD, Gerassimos A. Pangalis, MD

Blood (2006) 108 (11): 3522.

https://doi.org/10.1182/blood.V108.11.3522.3522

Published: 2006

Journal Articles

B-Chronic Lymphoproliferative Disorders (BCLD) Presenting with Splenomegaly: Differential Diagnosis and Outcome.

Maria K. Angelopoulou, MD, Maria Papakonstantinou, MD, Flora N. Kontopidou, MD, Maria N. Dimopoulou, MD, Marina P. Siakantaris, MD, Theodoros P. Vassilakopoulos, MD, Christina Kalpadakis, MD, Styliani Kokoris, MD, Evangelia M. Dimitriadou, MD, Zacharoula Galani, MD, Sotirios Sachanas, MD, Padelis Tsirkinidis, MD, Marie-Christine Kyrtsonis, MD, Penelope Korkolopoulou, MD, Panayiotis Panayiotidis, MD, Gerassimos A. Pangalis, MD

Blood (2006) 108 (11): 4655.

https://doi.org/10.1182/blood.V108.11.4655.4655

Published: 2006

Journal Articles

Evaluation of Microsatellite Instability in Gastric MALT Lymphomas.

Marina P. Siakantaris, MD, Maria K. Angelopoulou, MD, Konstantinos Lilakos, Yannis Metaxas, MD, Maria Moschoyianni, MD, Maria Gamaletsou, MD, Theodoros P. Vassilakopoulos, MD, Marie-Christine Kyrtsonis, MD, Penelope Korkolopoulou, MD, Panayiotis Panayiotidis, MD, Gerassimos A. Pangalis, MD

Blood (2006) 108 (11): 4625.

https://doi.org/10.1182/blood.V108.11.4625.4625

Published: 2006

Journal Articles

The Successful Use of Archived Formalin-Fixed Paraffin-Embedded (FFPE) Material for Gene Expression Studies.

Konstantinos Lilakos, Maria K. Angelopoulou, MD, George Georgiou, MD, Vassilios Salpeas, PhD, Penelope Korkolopoulou, MD, Panayiotis Panayiotidis, MD, Gerassimos A. Pangalis, MD

Blood (2006) 108 (11): 4637.

https://doi.org/10.1182/blood.V108.11.4637.4637

Published: 2006

Journal Articles

Rituximab-CHOP (R-CHOP) and Radiotherapy (RT) for Primary Mediastinal Large B-Cell Lymphoma (PMLBCL).

Blood (2006) 108 (11): 2745.

https://doi.org/10.1182/blood.V108.11.2745.2745

Published: 2006

Journal Articles

Z-Guggulsterone Downregulates Survivin and Induces Cell Death in Large B Cell Lymphoma Cells In Vitro.

Maria K. Angelopoulou, MD, Konstantinos Lilakos, Vassilios Salpeas, PhD, Sotirios Sachanas, MD, Penelope Korkolopoulou, MD, Marina P. Siakantaris, MD, Theodoros P. Vassilakopoulos, MD, Panayiotis Panayiotidis, MD, Gerassimos A. Pangalis, MD

Blood (2006) 108 (11): 4752.

https://doi.org/10.1182/blood.V108.11.4752.4752

Published: 2006

Journal Articles

Serum Soluble Syndecan-1 Levels at Diagnosis Constitute an Independent Prognostic Factor of Survival in Myeloma That May Further Differentiate Patients within the ISS Stages.

Marie-Christine Kyrtsonis, MD, Theodoros P. Vassilakopoulos, MD, Argyro Papadogiannis, MD, Tatiana Tzenou, MD, Christina Kalpadakis, MD, Antoine Antoniadis, MD, Maria N. Dimopoulou, MD, Marina P. Siakantaris, MD, Stella I. Kokoris, MD, Evangelia M. Dimitriadou, MD, Maria K. Angelopoulou, MD, Ellen Plata, MD, Panagiotis Tsaftaridis, MD, Gerassimos A. Pangalis, MD

Blood (2005) 106 (11): 3404.

https://doi.org/10.1182/blood.V106.11.3404.3404

Published: 2005

Journal Articles

The Activity of Combined Topoisomerase Inhibitors Is Augmented by Octreotide in the Treatment of Lymphoid Leukemias.

Dimitrios T.P. Trafalis, PhD, MD, Konstantinos Lilakos, PhD, Daphne Koumbi, PhD, Panayiotis Dalezis, PhD, Maria K. Angelopoulou, MD, Athanasios E. Athanassiou, MD, Athanasios Papageorgiou, PhD, Gerassimos A. Pangalis, MD

Blood (2005) 106 (11): 2475.

https://doi.org/10.1182/blood.V106.11.2475.2475

Published: 2005

Journal Articles

Retrospective Analysis of 41 Consecutive Patients with Non Gastrointestinal (GI) Extranodal Marginal Zone B-Cell Lymphoma (EMZL): Correlation of Clinical Characteristics and Outcome with Disease Localization.

Christina Kalpadakis, MD, Marina P. Siakantaris, MD, Marie-Christine Kyrtsonis, MD, Theodoros P. Vassilakopoulos, MD, Tatiana Tzenou, MD, Maria N. Dimopoulou, MD, Evangelia M. Dimitriadou, MD, Styliani I. Kokoris, MD, Maria K. Angelopoulou, MD, Fotios Mitropoulos, MD, Penelope Korkolopoulou, MD, Gerassimos A. Pangalis, MD.

Blood (2005) 106 (11): 4785.

https://doi.org/10.1182/blood.V106.11.4785.4785

Published: 2005

Journal Articles

Rituximab Monotherapy Is an Effective Treatment for Splenic Marginal Zone B-Cell Lymphomas (SMZL).

Maria N. Dimopoulou, MD, Christina Kalpadakis, MD, Evangelia M. Dimitriadou, MD, Marie-Christine Kyrtsonis, MD, Styliani I. Kokoris, MD, Panagiotis Tsaftaridis, MD, Flora N. Kontopidou, MD, Marina P. Siakantaris, MD, Eleni Plata, MD, Theodoros P. Vassilakopoulos, MD, Maria K. Angelopoulou, MD, Gerassimos A. Pangalis, MD.

Blood (2005) 106 (11): 4800.

https://doi.org/10.1182/blood.V106.11.4800.4800

Published: 2005

Journal Articles

Complex Paterns of Monoclonal Ig Diversification in B-CLL Cells from Different Tissue Compartments.

Evangelia M. Dimitriadou, MD, Panayiotis Panayiotidis, MD, Vasiliki Karali, MD, Konstantinos Lilakos, PhD, Maria K. Angelopoulou, MD, Marina P. Siakantaris, MD, Gerassimos A. Pangalis, MD

Blood (2005) 106 (11): 5021.

https://doi.org/10.1182/blood.V106.11.5021.5021

Published: 2005

Journal Articles

Bortezomib in Patients with Relapsed-Refractory Multiple Myeloma (MM). Clinical Observations.

Marie-Christine Kyrtsonis, MD, Sotirios Sachanas, MD, Theodoros P. Vassilakopoulos, MD, Nikoletta Kafassi, MD, Tatiana Tzenou, MD, Argyro Papadogiannis, MD, Christina Kalpadakis, MD, Antonios G. Antoniadis, MD, Maria N. Dimopoulou, MD, Maria K. Angelopoulou, MD, Marina P. Siakantaris, MD, Evangelia M. Dimitriadou, MD, Styliani I. Kokoris, MD, Eleni Plata, MD, Panagiotis Tsaftaridis, MD, Panayiotis Panayiotidis, MD, Gerassimos A. Pangalis, MD

Blood (2005) 106 (11): 5193.

https://doi.org/10.1182/blood.V106.11.5193.5193

Published: 2005

Journal Articles

Topoisomerase IIα (TopoIIα) Expression in Hodgkin’s Lymphoma (HL): Correlations with Conventional and Biological Markers and Prognostic Significance under Treatment with ABVD or Equivalent Regimens with or without Radiotherapy (RT).

Theodoros P. Vassilakopoulos, MD, Ipatia A. Doussis-Anagnostopoulou, MD, Despina Karandrea, Penelope Korkolopoulou, MD, Maria K. Angelopoulou, MD, Marina P. Siakantaris, MD, Styliani I. Kokoris, MD, Evangelia M. Dimitriadou, MD, Maria N. Dimopoulou, MD, Christina Kalpadaki, MD, Maria-Christina Kyrtsonis, MD, Irini Thymara, MD, Nikolaos Kavantzas, MD, Panayiotis Panayiotidis, MD, Efstratios Patsouris, MD, Christos Kittas, MD, Gerassimos A. Pangalis, MD

Blood (2005) 106 (11): 967.

https://doi.org/10.1182/blood.V106.11.967.967

Published: 2005

Journal Articles

Excellent Outcome with Rituximab-CHOP (R-CHOP) Combined with Radiotherapy (RT) in Primary Mediastinal Large B-Cell Lymhoma (PMLBCL).

Theodoros P. Vassilakopoulos, MD, Maria K. Angelopoulou, MD, Zacharoula Galani, MD, Sotirios Sachanas, MD, Andreas Katsigiannis, MD, Maria N. Dimopoulou, MD, Styliani I. Kokoris, MD, Evridiki Michalis, MD, Evangelia M. Dimitriadou, MD, Marina P. Siakantaris, MD, Flora N. Kontopidou, MD, Christina Kalpadakis, MD, Angelos Sarantopoulos, MD, Pinelopi Korkolopoulou, MD, Paraskevi Roussou, MD, Gerassimos A. Pangalis, MD

Blood (2005) 106 (11): 935.

https://doi.org/10.1182/blood.V106.11.935.935

Published: 2005

Journal Articles

Molecular Analysis of the VH Gene Usage in a Familial Case of Waldenstrom’s Macroglobulinemia.

Marina P. Siakantaris, MD, Marie-Christine Kyrtsonis, MD, Konstantinos Lilakos, Maria K. Angelopoulou, MD, S. Vavourakis, MD, Flora N. Kontopidou, MD, Theodoros P. Vassilakopoulos, MD, Christina Kalpadakis, MD, Styliani I. Kokoris, MD, Evangelia M. Dimitriadou, MD, Constantin Kilindireas, MD, Gerassimos A. Pangalis, MD

Blood (2005) 106 (11): 1005.

https://doi.org/10.1182/blood.V106.11.1005.1005

Published: 2005

Journal Articles

Lymhoma of the Oral Cavity. A Rare Entity with Favorable Prognosis. Ten-Year Experience of a Single Hematology Unit.

Marina P. Siakantaris, MD, Tatiana Tzenou, MD, Theodoros P. Vassilakopoulos, MD, Marie-Christine Kyrtsonis, MD, Maria K. Angelopoulou, MD, Maria N. Dimopoulou, MD, Styliani I. Kokoris, MD, Evangelia N. Dimitriadou, MD, Penelope Korkolopoulou, MD, Efstratios Patsouris, MD, Panayiotis Tsaftaridis, MD, Eleni Variamis, MD, George Laskaris, MD, Gerassimos A. Pangalis, MD

Blood (2004) 104 (11): 4595.

https://doi.org/10.1182/blood.V104.11.4595.4595

Published: 2004

Journal Articles

Interferon Alpha-2B (IFN-a) Is an Effective Agent for the Treatment of Primary Cutaneous T- and B-Cell Lymphoma.

Marina P. Siakantaris, MD, Marie-Christine Kyrtsonis, MD, Tatiana Tzenou, MD, Evangelia M. Dimitriadou, MD, Maria N. Dimopoulou, MD, Maria K. Angelopoulou, MD, Styliani I. Kokoris, MD, Theodoros P. Vassilakopoulos, MD, Penelope Korkolopoulou, MD, Antonia Giannakakis, MD, Eleni Plata, MD, Eustratios Patsouris, MD, Andreas Katsambas, MD, Gerassimos A. Pangalis, MD

Blood (2004) 104 (11): 2643.

https://doi.org/10.1182/blood.V104.11.2643.2643

Published: 2004

Journal Articles

Serum Soluble Syndecan-1 Levels Correlate with Erythropoietin and Inversely with Hemoglobin Levels in Untreated Anaemic Myeloma Patients: Possible Role of Syndecan-1 in the Mechanisms of Chronic Anaemia.

Marie-Christine Kyrtsonis, MD, Theodoros P. Vassilakopoulos, MD, Argyro Papadogiannis, MD, Tatiana Tzenou, MD, Maria N. Dimopoulou, MD, Marina P. Siakantaris, MD, Styliani I. Kokoris, MD, Evangelia Dimitriadou, MD, Maria K. Angelopoulou, MD, Christine Kalpadaki, MD, Gerassimos A. Pangalis, MD

Blood (2004) 104 (11): 4882.

https://doi.org/10.1182/blood.V104.11.4882.4882

Published: 2004

NARROW

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) of the Salivary Gland Is Associated with Improved Prognosis When Arising in a Background of Sjögren’s Disease and May Not Benefit from Local Therapy

The Addition of sFLCR Improves ISS Prognostication in Multiple Myeloma (MM).

Serum Free Light Chain Ratio (FLCR) at Diagnosis Constitute a Powerful Prognostic Factor of Survival in Multiple Myeloma (MM).

B-Chronic Lymphoproliferative Disorders (BCLD) Presenting with Splenomegaly: Differential Diagnosis and Outcome.

Evaluation of Microsatellite Instability in Gastric MALT Lymphomas.

The Successful Use of Archived Formalin-Fixed Paraffin-Embedded (FFPE) Material for Gene Expression Studies.

Rituximab-CHOP (R-CHOP) and Radiotherapy (RT) for Primary Mediastinal Large B-Cell Lymphoma (PMLBCL).

Z-Guggulsterone Downregulates Survivin and Induces Cell Death in Large B Cell Lymphoma Cells In Vitro.

Serum Soluble Syndecan-1 Levels at Diagnosis Constitute an Independent Prognostic Factor of Survival in Myeloma That May Further Differentiate Patients within the ISS Stages.

The Activity of Combined Topoisomerase Inhibitors Is Augmented by Octreotide in the Treatment of Lymphoid Leukemias.

Retrospective Analysis of 41 Consecutive Patients with Non Gastrointestinal (GI) Extranodal Marginal Zone B-Cell Lymphoma (EMZL): Correlation of Clinical Characteristics and Outcome with Disease Localization.

Rituximab Monotherapy Is an Effective Treatment for Splenic Marginal Zone B-Cell Lymphomas (SMZL).

Complex Paterns of Monoclonal Ig Diversification in B-CLL Cells from Different Tissue Compartments.

Bortezomib in Patients with Relapsed-Refractory Multiple Myeloma (MM). Clinical Observations.

Topoisomerase IIα (TopoIIα) Expression in Hodgkin’s Lymphoma (HL): Correlations with Conventional and Biological Markers and Prognostic Significance under Treatment with ABVD or Equivalent Regimens with or without Radiotherapy (RT).

Excellent Outcome with Rituximab-CHOP (R-CHOP) Combined with Radiotherapy (RT) in Primary Mediastinal Large B-Cell Lymhoma (PMLBCL).

Molecular Analysis of the VH Gene Usage in a Familial Case of Waldenstrom’s Macroglobulinemia.

Lymhoma of the Oral Cavity. A Rare Entity with Favorable Prognosis. Ten-Year Experience of a Single Hematology Unit.

Interferon Alpha-2B (IFN-a) Is an Effective Agent for the Treatment of Primary Cutaneous T- and B-Cell Lymphoma.

Serum Soluble Syndecan-1 Levels Correlate with Erythropoietin and Inversely with Hemoglobin Levels in Untreated Anaemic Myeloma Patients: Possible Role of Syndecan-1 in the Mechanisms of Chronic Anaemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only